Publication: 4444

Publication: 4444

Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Cancer vol 131 (4) e35750

Year:: 2025
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub-ppub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No
Book Volume:: 15

Parents:: 66
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: Bayer Healthcare
Grants:: U10CA180821, U24CA196171, U10CA180882, UG1CA189824, UG1CA189850, UG1CA233180, UG1CA233191, UG1CA233327, UG1CA233331, UG1CA233339

Corr. Author:
Authors:: Marlise R. Luskin Jun Yin Gerard Lozanski Emily Curran Gregory Malnassy Krzysztof Mrózek Clara D. Bloomfield Spero R. Cataland Noreen Fulton Jonathan Kolitz Betsy Laplant Oudom Kour Bayard L. Powell Ravi Vij Eunice S. Wang David Grinblatt Richard M. Stone Geoffrey L. Uy Richard A. Larson Wendy Stock

Networks:: IL018, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-MO011, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL, OH070

Study: CALGB-10102
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: